Clinical Trials in Philadelphia

Showing 4921-4940 of 20,904 trials

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

NCT04434040

The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: * Sacituzumab govitecan * Atezolizumab

Breast CancerTriple Negative Breast CancerResidual Cancer+1 more

Dana-Farber Cancer Institute40 participantsStarted Jul 2020

San Francisco, California, United States • Chicago, Illinois, United States • New Lenox, Illinois, United States +4 more locations

COMPLETEDNA< 1 mile

EHR-integrated rUTI Texting Platform

NCT06035601

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

Recurrent Urinary Tract Infection

University of Pennsylvania104 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

EHR-integrated rUTI Texting Platform

Find Trials by Condition in Philadelphia

Combined Therapeutic Air Mixture and Electrical Stimulation to Improve Breathing and Hand Function in Spinal Cord Injury

Fiber Food Introduction in Pediatric Short Bowel Syndrome

VIZ ACCESS HCM - Multi-Site Registry

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

Examining the Circadian Timing Effects of the Hypotensive Response to Exercise

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

A Study of ADRX-0706 in Select Advanced Solid Tumors

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)